The Enterprise Value as of September 2024 (TTM) for MediWound Ltd. (MDWD) is 193.58M

According to MediWound Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 193.58M. This represents a change of 78.69% compared to the average of 108.33M of the last 4 quarters.

MediWound Ltd. (MDWD) Historical Enterprise Value (quarterly & annually)

How has MDWD Enterprise Value performed in the past?

The mean historical Enterprise Value of MediWound Ltd. over the last ten years is 83.35M. The current 193.58M Enterprise Value has changed 23.13% with respect to the historical average. Over the past ten years (40 quarters), MDWD's Enterprise Value was at its highest in in the June 2018 quarter at 181.00M. The Enterprise Value was at its lowest in in the September 2022 quarter at 29.90M.

MediWound Ltd. (MDWD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of MediWound Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MediWound Ltd. (MDWD) Average Enterprise Value

How has MDWD Enterprise Value performed in the past?

The current Enterprise Value of MediWound Ltd. (MDWD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

MediWound Ltd. (MDWD) Enterprise Value vs. Peers

How is MDWD’s Enterprise Value compared to its peers?

MediWound Ltd.’s Enterprise Value is less than Foghorn Therapeutics Inc. (430.91M), less than Eliem Therapeutics, Inc. (312.10M), less than Sutro Biopharma, Inc. (423.40M), greater than Dyadic International, Inc. (33.63M), less than Crinetics Pharmaceuticals, Inc. (3.97B), greater than Inhibrx, Inc. (21.26M), less than Merus N.V. (2.75B), less than Lyell Immunopharma, Inc. (272.40M), greater than Kronos Bio, Inc. (12.40M), greater than Aerovate Therapeutics, Inc. (24.75M), less than Keros Therapeutics, Inc. (1.70B), less than Syndax Pharmaceuticals, Inc. (1.43B), less than Mineralys Therapeutics, Inc. (513.45M), less than Replimune Group, Inc. (681.29M), less than Ocular Therapeutix, Inc. (1.03B), less than Veracyte, Inc. (2.38B), less than Avidity Biosciences, Inc. (4.66B), less than SpringWorks Therapeutics, Inc. (2.57B), less than Monte Rosa Therapeutics, Inc. (300.68M), less than Nkarta, Inc. (337.02M), less than Generation Bio Co. (238.32M), less than Sana Biotechnology, Inc. (914.15M),

Build a custom stock screener for MediWound Ltd. (MDWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediWound Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MediWound Ltd. (MDWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MediWound Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.